DR. ALAIN L. FYMAT, PhD, PhD is a medical-physical scientist and an educator. He is the current President/CEO and Professor at the International Institute of Medicine & Science with a previous appointment as EVP/COO and Professor at the Weil Institute of Critical Care Medicine, California, U.S.A. He was formerly Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine and Physics at several U.S. and European Universities. Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of Radiology, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology. Previously, he was also Director of the Division of Biomedical and Biobehavioral Research at the University of California at Los Angeles/Drew University of Medicine and Science. He is also Health Advisor to the American Heart & Stroke Association, Coachella Valley Division, California. He is a frequent Keynote Speaker and International Organizing Committee member at several international scientific conferences. He has lectured extensively in the U.S., Europe, Asia and Africa. He has published ~ 425 scholarly scientific publications and books. He is also Editor-in-Chief, Honorable Editor or Editor of 54 scientific Journals. Dr. Fymat is a Board member of several institutions, a member of the New York Academy of Sciences and a reviewer for the prestigious UNESCO Newton Prize, United Kingdom National Commission for UNESCO. His current research interests are focused on neurodegenerative diseases (Alzheimer, Parkinson, epilepsy, dementias and others), oncology, molecular/precision/personalized medicine, and nanomedicine and nanobiotechnology.
Dr. Fymat’s current research interests lie at the interface between science and medicine, particularly cancer/oncology, molecular/personal/precision medicine, nanomedicine, human genetics/ epigenetics/ ecogenetics, neurodegenerative diseases, and pharmacogenomics. His most recent publications deal with nanotechnology and cancer, nanochemotherapy, nanoneurology, natural and synthetic immunotherapy, drug delivery across the brain protective barriers, and neurodegenerative disorders (epilepsy, Parkinson's and Alzheimer's diseases).
Specialities: Board Certified Toxicologist, specializing in environmental and human health impacts of harmful chemicals, especially in aquatic environments, and focusing on Asia, esp. China, and W. Pacific. Much Experience and first-hand knowledge with pollution problems in marginal seas of the Western Pacific, especially China (Qingdao area). Also much experience with pollution problems and issues in Pearl River Delta, Guangdong Province /Guangzhou region.
Research Interest: Development and application of new sample preparation techniques including: "Liquid Phase Microextraction (LPME)"; "Solid Phase Microextraction (SPME)"; "Membrane Extraction with Sorbent Interface (MESI)" and "Solid Phase Extraction (SPE)" for trace analysis of organic/ inorganic compounds in food, environmental and biological samples.
László Forró obtained his B.S. at Eötvös Loránd University, Budapest and M.S. at Université Paris XI in physics. He received his PhD at the University of Zagreb in 1985. He is a full professor at the Ecole Polytechnique Fédérale de Lausanne, where he holds the chair of Nanostructures and Novel Electronic Materials. In his Laboratory of Physics of Complex Matter (http://lpmc.epfl.ch/), he is leading an interdisciplinary research activity. Within the School and beyond he tries to create an experiment-driven partnership with a scientific focus on the correlated matter, the design of new nanostructured materials and biological physics. This vision has led him to the organization of a bi-annual conference in Dubrovnik (http://dubrovnik.epfl.ch/) with the theme: From Solid State to Biophysics (since 2002).
Novel electronic materials, Functional nanostructures, Biomaterials, Toxicity
Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver. He published more than 647 peer-reviewed research papers and registered 14 UK and International patents. On editorial boards of 41 journals. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career, Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement; include BBC, ITV, WSJ, CNN, and many more. Currently, he is working on the development and commercialisation of human organs using graphene-based nanocomposite materials and stem cells technology. He has commercialised a novel functionalised graphene oxide for medical and other industrial applications. He also commercialised new biodegradable nanocomposite materials for medical and other industrial applications. He is British citizen and completed his school in UK (concord college) and his scientific training at London University.
Nanotechnology and Regenerative Medicine Nanotechnology and Regenerative Medicine Nanotechnology and Regenerative Medicine Breast Cancer and Regenarative Medicine Breast Cancer and Regenarative Medicine Stem cells, Bio-materials and Regenerative medicine Stem cells, Bio-materials and Regenerative medicine Regenerative Medicine and stem cells. Nanotechnology
Dr. Hermis Iatrou is presently working as a Professor in the Department of Chemistry, University of Athens, Athens, Greece. He also works as a Director of the Industrial Laboratory of the Chemistry Department at the University of Athens, Greece since 2015. He received his Ph.D. from the University of Athens, Greece. He also completed his first post-doctoral fellowship at the “Institute of Festo-cooperative Research Center Juelich, Germany (1993-1995) and second Post-Doctoral Fellowship in the University of Alabama at Birmingham, USA (1997-1998). He was one of the discoverers who synthesized Star Polymers, in which chemically different polymeric chains emanated from the same central point. He has participated as a faculty member of some international and national projects such as STF-NATO GR Project on Hydrogenation with nanoparticles and INTAS. He was also awarded a project to develop nanoparticles, nanogels, and hydrogels to treat pancreatic cancer in 2012. He has guided Masters, Ph.D. degree and post-doctoral fellowship students for their project work. He was an author and co-author of various peer-review publications. He is a member of various International and national organizations. He was participated in international and national conferences and gives presentations. He also serves as a reviewer of some peer review journals.
Polymer Synthesis, Polymer Characterization and their Properties, and Solid State Properties of Polymers.
James E. Trosko has completed his Ph.D. at the age of 25 from Michigan State University, USA. He is a Distinguished Emeritus Professor at Michigan State University. He spent 3 years as a postdoctoral fellow at Oak Ridge National Laboratory under Drs. Ernest Chu; Dr. Sheldon Wolff and Dr. Richard Setlow. After joining Michigan State University, he obtained an NCI- Career Development award; spent one year at the McArdle Lab for Cancer Research at the University of Wisconsin under Dr. Van R. Potter. Later he was Chief of Research at the Radiation Effects Research Foundation for two years in Hiroshima and Nagasaki, Japan. He spent 2 years at Seoul National University as a Korean “World Class University Professor”. He also spent one year at the ARNAS-Civico-Regional Cancer Hospital in Palermo, Sicily. He has over 450 publications that have been cited over 17,000 times, and his publication H-index is 62.
Epigenetics, Pharmacology, Drug Discovery, Toxicology
Aizman Roman Idelevich is Doctor of Biological Sciences, Professor, Honored Worker of Science of Russia, Head of the Department of Anatomy, Physiology and Safety, Director of the Institute of Health and Safety. He is a Member of 3 dissertation councils for doctoral theses, a Foreign Member of the American Physiological Society, a valid Member of the European Society of Pediatric Nephrology and an Associate Editor of two scientific journals. He is the author of over 500 scientific and methodical works, including 28 monographs, 90 manuals, 367 articles in refereed journals and 16 proposals, patents and registration certificates. He was awarded Diplomas of the Ministry of Education of the Russian Federation, Ministry of Emergency Situations, the Administration of the City and Region (Novosibirsk) the Medal Property of Siberia, K. D. Ushinsky Medal, etc
Epigenetics, Pharmacology, Drug Discovery, Toxicology
Dr. DeGarmo is a Professor Emerita at Southern Illinois University Edwardsville, USA and research associate for the Applied Research Institute in Jerusalem. Her expertise consists of international security with a focus on the nuclear era and security in the Middle East. She has also been a facilitator for the Foreign Policy's Great Decisions program at the university since 2001. Dr. DeGarmo previously spent several years as a department chair of the political science department at Southern Illinois University Edwardsville. A recipient of numerous research grants over the years, she has also received numerous awards for her contributions, including a Meridian Award for 2011 and 2012, and a Dr. Martin Luther King Jr. Humanitarian Award in 2011, all granted by Southern Illinois University Edwardsville. She has also been named as the recipient of the “Lifetime Achievement Award” and “Who’s Who of Professional Women” by Marquis in 2017. She also served on the Organizing Committee and as Keynote Speaker for “Environmental Toxicology and Ecological Risk Assessment”September 24-25, 2018 Chicago, Illinois, USA. Professor DeGarmo has authored four books, "The Geneva Conventions of 1949 and Their Protocols: The Case of Israel" in 2016, “The U.S.-Israeli Strategic Alliance and the Disappearing Palestine” in 2016, “The Disposal of Radioactive Wastes in the Metropolitan St. Louis Area: The Environmental and Health Legacy of the Mallinckrodt Chemical Works” in 2006, and “International Environmental Treaties and State Behavior: Factors Influencing Cooperation,” in 2004. She has also written a number of book chapters, contributions to both encyclopedias and professional journals, and undergraduate teaching manuals. Beyond those literary accomplishments, Dr. Degarmo has conducted over two dozen book and article reviews, and has served as a presenter and chair for many conference proceedings since 1994.
The nuclear era and security in the Middle East
Yazen M Alnouti is an Assistant Professor in the Department of Pharmaceutical Sciences, University of Nebraska Medical Center. He worked as a Research Assistant Professor in the Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center. he received his Post Doctorate from University of Kansas Medical Center. He was selected by Selected by “Who’s Who in America” as a scientist with outstanding achievements in the year 2009. He has a Professional membership in American Association of Colleges of Pharmacy (AACP). He experienced as a Teaching & Research Assistant in the College of Pharmacy, University of Georgia. His highlights of Research expertise include Drug Metabolism and Disposition, High-Throughput Bioanalytical Chemistry and Pharmacokinetics.
application of bioanalytical chemistry, in vitro models such as microsomes and stably-transfected cell lines, and in vivo animal models such as knock-out mice, to support ADMET (absorption, distribution, metabolism, excretion, and toxicity) and pharmacokinetics studies.
Dr. Mauro Luisetto, obtained his Pharm D in 1995 from the Turin University and worked as European specialist in laboratory medicine. Currently, he works as Public Hospital Pharmacist Manager and is responsible of hospital medicinal gas quality control PC HOSP. He is also the Director of hospital medicinal gases contract implementation. His working filed and rotation is biochemistry, toxicology, blood bank, haematology. microbiology; hospital pharmacy (drugs logistic, galenic, medicinal gas quality controller , radio drugs, rx contrast agents, departmental pharmacist); clinical pathology, antidothes responsible stokes provincial PC, logistic of diagnostic in vitro), responsible for emergency drug hospital stokes.
Pathology, clinical biochemistry , toxicology, microbiology, imaging, clinical pharmacy , ph care , medicinal chemistry clinical pharmacology, pharmacoeconomy, new professional social media, biomedical database, EBM and risk management.
Inflammation, Chemokines and Immunopathology-, INSERM, Univ Paris-Sud, Université Paris-Saclay, 92296 Châtenay-Malabry, France
Rapid Anxiolytic Effects of a 5-HT4 Receptor Agonist Are Mediated by a Neurogenesis-Independent Mechanism
Dr. Al Naggar (1986) is a lecturer of entomology and ecotoxicology at Zoology Department, Faculty of Science, Tanta University. He got his B. Sc. and M.Sc. degrees from zoology department, faculty of science, Tanta University, Egypt in 2007 and 2011 respectively. Then he traveled to Canada, where he joined to Prof. John Giesy group at toxicology center, Saskatchewan University for his PhD project from 2012-2015. So, he has a great experience in beekeeping, pesticides toxicology, molecular techniques and ecological risk assessment of pesticides on bees. Moreover, his ongoing research is directed toward the adverse effects of agrochemicals and heavy metals nanoparticles on honey bee health. He has published more than 15 peer-reviewed journal articles. Dr Al Naggar has been awarded the scientific publication award several times from Tanta University, Egypt. Currently, he serves as a reviewer for more than 15 peer-reviewed journals and member in editorial board of several journals. On 1st of July 2018, he will join University of California at Riverside for six months as a postdoc fellow so during the meeting he will be at USA. Also, he recently have been awarded the German Alexander von humboldt postdoc fellowship to start by 1st of January 2019.
Dr. Yahya Al Naggar’s research interest includes Ecological Risk Assessment of Pesticides and heavy metals on living organisms. Reasons of Honey bee colony losses (Colony Collapse Disorders; CCD). Fate of Environmental toxins in water, soil and in living organisms. Bee toxicology and insect molecular toxicology. Beekeeping, Varroa mite control and bee pathogens.
Dr. Ahmed G. Hegazi is working as a professor of Microbiology & Immunology at National Research Center, Dept. Zoonotic Diseases from 2004.He also has work experience as prestigious chair in Dept.of Parasitology and Animal Diseases,National Research Center. He received many awards like Senior Scientist Prize of National Research Center(1996),National Scientific Prize In Biological Sciences(1990),The Second Best Research Paper award From International Congress of propolis, Bones Aires, Argentina(2000) and many more. He Conducted training courses on Clinical Microbiology, National Research Center in 1979. He has 225 articles in national and international scientific journals along with four patents.
Microbiology and Immunology
Dr. Ghada Saad Zaghloul Ahmed Mahmoud is currently working as a Lecturer in the Department of Physiology, Assuit University , Egypt. His research interests includes rat hippocampus , area CA1 , excitatory synaptic transmission , Growth hormone , Neuroscience , Neuroendocrinology. He /she is serving as an editorial member and reviewer of several international reputed journals. Dr. Ghada Saad Zaghloul Ahmed Mahmoud is the member of many international affiliations. He/ She has successfully completed his Administrative responsibilities. He /she has authored of many research articles/books related to rat hippocampus , area CA1 , excitatory synaptic transmission , Growth hormone , Neuroscience , Neuroendocrinology.
Prof. Stoycho Stoev is currently a Head of Dept. of General and clinical pathology in Fac. of Veterinary medicine of Trakia University in Bulgaria. He has been a Project leader of 4 international research projects (regarding mycotoxic nephropathy in farm animals and humans) funded by National Science Fund of Ministry of Science and Education in Bulgaria; Bulgarian Project Leader of Joint Research Project between Bulgaria and UK funded by The Royal Society - London (1997-2000); The main Pathologist in eight Joint International Research Projects between Bulgaria and Germany funded by International Pharmaceutical Strategies and Solutions (IPSS) GmbH – Germany (2005-2007); Marie Curie Outgoing International Fellow in University of Johannesburg and Rhodes University in S. Africa under the project addressed the cause of porcine/chicken/human nephropathies in Bulgaria and South Africa (2007-2008 in FP6 of EU and 2013 in FP7 of EU) and Marie Curie Fellow in the Institute of Nuclear Medicine and Allied Sciences (INMAS) in Defence Research and Development Organisation (DRDO) in India under the project studied some herbal additives giving partial protection against toxic or immunosuppressive effects of some mycotoxins (2014 in FP7 of EU); Coordinator of Marie Curie PIRSES project “HERBAL PROTECTION” of FP7 of EU between Bulgaria, Hungary, India and South Africa (2013-2016). He has specializations in Imperial College of Science, Technology and Medicine - London, U.K (1998 - Royal Society project) and in Laboratoire de Toxicologie et S?curity Alimentaire, Toulouse, France (2000 - NATO grant) and many specializations or invited lectures at several universities in Hungary, S. Africa and India. Recently he was a Visiting Professor in Department of Food Technology of Faculty of Science at the University of Johannesburg (2013-2016). He has more than 100 publications in peer reviewed international journals, international books or chapters of books and above 1400 quotations of the same publications; H-index in Scopus – 20.
mycotoxins, fumonisins, ochratoxin A, toxicologic pathology, histopathology
Dai-Yeun Jeong is presently the Director of Asia Climate Change Education Center and Acting Director of Jeju Secretariat, UNESCO World Network of Island and Coastal Biosphere Reserves and also an Emeritus Professor of Environmental Sociology at Jeju National University in South Korea. He received BA and MA Degree in Sociology from Korea University (South Korea), and PhD in Environmental Sociology from The University of Queensland (Australia). He was a Professor of Sociology at Jeju National University (South Korea) from 1981 to 2012. His past major professional activities include a Teaching Professor at the University of Sheffield in UK, the President of Asia-Pacific Sociological Association, a Delegate of South Korean Government to UNFCCC, a Delegate of South Korean Government to OECD Environmental Meeting, and a Member of Presidential Commission on Sustainable Development, Republic of Korea, etc. He has published 60 environment-related research papers in domestic and international journals and 13 books including Environmental Sociology. He has conducted 91 unpublished environment-related research projects funded by domestic and international organizations.
Maria Teresa is a Pharmacist, has a Degree and a Master in Pharmaceutical Sciences from the Faculty of Pharmacy, University of Coimbra. Has a Master in Food Science and Engineering from the School of Biotechnology, Portuguese Catholic University, a PhD in Public Health and Pharmacoepidemiology from the Faculty of Medicine, University of Santiago de Compostela and a Post-Doctoral Scholarships by Fundação para a Ciência e Tecnologia, SFRH/BPD/35746/2007, during 6 years in Pharmacoepidemiology and Pharmacovigillance. She is a Regulatory Affairs Expert, since 2002 by Portuguese Pharmacist College. She was Technical Director, Quality Director and responsible for Regulatory Affairs, Pharmacovigilance and Clinical trials, for more than 6 years in Pharmaceutical Industry. Since 2006, she is an Invited Assistant Professor at the Department of Medical Sciences at University of Aveiro, holding responsibility for several curricular units in the Biomedical Sciences degree and in the master in Pharmaceutical Biomedicine.
Herdeiro research experience included the design, implementation and evaluation of epidemiological studies, randomized controlled trials, cohort, case-control, cross-sectional studies, qualitative studies (focus group) and systematic reviews
Michal H. Wrobel is currently Associate Professor at the Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences in Olsztyn (Poland). He earned his MSc of Biology at the University of Warmia and Masury in Olsztyn, in 2002, and his PhD in Faculty of Biology from the University of Warmia and Masury in Olsztyn, in 2008. In his thesis work he pioneered the adverse effect of chlorinated xenobiotics (polichlorinated biphenyls and pesticides) on bovine myometrial contractions. After completing his MSc, Michal H. Wrobel accepted a position as Assistant in Department of Cattle Physiology and Endocrinology of the Institute of Animal Reproduction and Food Research, Polish Academy of Sciences. In 2009, he accepted an Associate Professor position at the Department of Physiology and Toxicology of Reproduction of the Institute of Animal Reproduction and Food Research, Polish Academy of Sciences. In 2011 he was awarded with individual Bielanski?s Prize by Association of Biology of Reproduction. Michal H. Wrobel has 24 refereed publications.
Physiology and Toxicology
Dr. Ian James Martins is an Editor/Reviewer for Open Acess Pub/MDPI journals and various other international journals. Advisory Board Member for Photon Journal. Fellow of International Agency for Standards and Ratings (IASR). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Chief Editor for International Journal of Diabetes Research (2014-2018), Research and Reviews: Neuroscience (2016-2018) and Journal of Diabetes and Clinical Studies (2017-2018). BIT Member (BIT Congress. Inc) with an h-index of 65, (ResearchGate STATs (28), Scopus Author ID: 7103152779/Mendeley STATS (21), UWA Research Repository (16). Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu. The citations past 27 years have accumulated to >4741. Ian James Martins - Semantic Scholar https://www.semanticscholar.org/author/Ian-James-Martins/5258067. Semantic Scholar profile for Ian James Martins, with fewer than 50 highly influential citations RESEARCHGATE ANALYSIS: Ian J Martins | Ph D | Centre of Excellence for Alzheimer's Disease ...https://www.researchgate.net/profile/Ian_Martins2 under Ian James Martins’ name places publication RG score (> 96%) of international SCIENTISTS. ORCID CONNECTING RESEARCHER: Editorial Team www.macrothink.org/journal/index.php/jfs/about/editorialTeamBio/13511 Editorial Team. Ian James Martins. Ian James Martins Mail • http://orcid.org/0000-0002-2390-1501. Edith Cowan University, Australia. Prestigious Recognition of Lifetime Membership by the International Agency for Standards and Ratings as Fellow for Diabetes, Medical Science (Nutrition). Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition). Certificates from various international conferences have been received in relation to anti-aging, health, and disease. Keynote addresses at, Biomedicine 2018 (Osaka, Japan), Global Experts Meeting on Diabetes, Hypertension, Metabolic Syndrome 2018 (Melbourne, Australia), Immunology World 2018 (Amsterdam, Netherlands), Laboratory Medicine 2018 (Berlin, Germany), Innovate Pharma 2017 (Sydney, Australia), Innovate Neurology 2017(Sydney, Australia) World Diabetes and Endocrinology Summit-2017 (Dubai), Pharmacology and Ethnopharmacology 2016 (Chicago, USA) and AGHC 2016 (1st Plenary Speaker, Kaohsiung, Taiwan). Chair/Co-chair Sessions on Laboratory management, Cytogenetics, Clinical Microbiology, Diagnostic Laboratory Medicine etc, 13th International Conference on Laboratory Medicine and Pathology, Berlin, Germany, June 25-26, 2018, Chairing Sessions on Vaccinology, Immunopathology, Immunotherapy, Immune Proteomics, Cancer and Tumour Oncology, 7th World Congress on Immunology, Amsterdam, Netherlands, April 19-20, 2018, Chair, Pipeline 1: Biotherapeutics for Diseases, Bit's 2nd International Congress of Biotherapy-2018 (Programme Committee Member), Chair, Innovate Conferences 2017, Chair/Co-Chair at congress World Gene Convention-2016 (Shanghai, China, Pharmacology and Ethnopharmacology 2016 (Chicago, USA), Annual World Congress of Diabetes-2014 (Haikou, China), World Gene Convention-2014 (Haikou, China). Research Activity Statistics provided by Publons with a comparison to other researchers indicates Ian James Martins to be a VERIFIED REVIEWER. Ian James Martins is now in the 98th percentile as assessed for Publons users by merit. Dr. Ian Martins is a reviewer for approx. 90 journals over the past 5 years. Organizing Committee and Advisory Board Member [h-index=65] (approx. 30 conferences): Organizing Committee Member, 3rd International conference on Neurology and Brain Disorders Milan Italy.during 25-26,2019, Organizing Committee Member Future Trends in Neurosciences 2019 Brussels, Belgium, Organizing Committee Member, 14th International Conference on Laboratory Medicine & Pathology in London, UK, Organizing Committee Member, 7th International Conference on Neurology and Neuromuscular Diseases that is slated on October 22-23, 2018 at Madrid, Spain, Organizing Committee Member 3rd Edition of International Conference on Neurology and Brain Disorders (INBC 2019), Organizing Committee Member, Euro Diabetes 2019 Congress, Edinburgh, Scotland Advisory Committee Member, 2nd International Conference on Medicinal Chemistry & Drug Design” (Medicinal Chemistry-2019) during August 19-20, 2019 in Barcelona, Spain, Advisory Board Member, Global Experts Meeting on Frontiers in Nanomedicine and Drug Delivery” (Nanodelivery 2019) scheduled during March 18-20, 2019 at London, UK, Organizing Committee Member, Conference on Food Science and Nutrition, 25 -26 February 2019,Rome, Italy, International Conference on PharmScience Research & Development” scheduled in Paris, France during March 04-06, 2019, Advisory Board Member World conference on Microbiology and Immunology2019, May 13-15th , 2019 Cape town, South Africa, Advisory Board Member 5th Neurological Disorders summit (NDS-2019) in Los Angeles, Organizing Committee Member, International Conference on Traditional Medicine and Ethno botany held at the Valencia, Spain on April 10-12, 2019, Organizing Committee Member, International Conference on Stem Cells, Biobanking and Tissue Preservation scheduled during 12-13th December 2018 at Abu Dhabi, UAE, Organizing Committee Member, International Conference on Heart & Diabetes" (ICHD 2019) along with external scientific association with the researches, academicians, and Pharmaceutical market leaders around the globe, scheduled on August 19-20, 2019 at Osaka, Japan, Organizing Committee Member, 2nd International Pharmaceutical Conference and Expo to take place on June 05-07, 2019 in Baltimore, USA, Advisory board member, International Summit on Vaccines and Immunology” (AEM VACCINES-2018) which is scheduled to be held on the 05th - 06th December 2018, etc.
Anti-Aging, Global Health and Chronic Disease
1) Identification and valid of pain molecules and signal transduction pathways; 2) Reverse pain pharmacology of herbal medicines; 3) Discovery and development of painkillers.